The shrinking lungs syndrome in systemic lupus erythematosus

Kenneth J Warrington, Kevin G. Moder, W. Mark Brutinel

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

A comprehensive review of the literature on shrinking lungs syndrome (SLS) in systemic lupus erythematosus involved a MEDLINE search (1965-1997) of case reports and clinical series of patients with the diagnosis of SLS. A total of 49 well-documented cases of SLS were reviewed. Shrinking lungs syndrome is characterized by unexplained dyspnea, a restrictive pattern on pulmonary function test results, and an elevated hemidiaphragm. The cause of SLS remains controversial, with several authors attributing the disorder to diaphragmatic weakness and others suggesting that chest wall restriction accounts for the clinical syndrome. No definitive therapy exists. Corticosteroids have been reported to lessen symptoms and improve pulmonary function in some patients with SLS, but other methods of treatment have occasionally been found to be helpful. Clinical presentation, method of diagnosis, pathogenesis, and treatment modalities are summarized in this review. An uncommon complication of systemic lupus erythematosus, SLS causes significant morbidity and, occasionally, mortality.

Original languageEnglish (US)
Pages (from-to)467-472
Number of pages6
JournalMayo Clinic Proceedings
Volume75
Issue number5
StatePublished - 2000

Fingerprint

Systemic Lupus Erythematosus
Lung
Respiratory Function Tests
Thoracic Wall
MEDLINE
Dyspnea
Adrenal Cortex Hormones
Therapeutics
Morbidity
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The shrinking lungs syndrome in systemic lupus erythematosus. / Warrington, Kenneth J; Moder, Kevin G.; Mark Brutinel, W.

In: Mayo Clinic Proceedings, Vol. 75, No. 5, 2000, p. 467-472.

Research output: Contribution to journalArticle

Warrington, KJ, Moder, KG & Mark Brutinel, W 2000, 'The shrinking lungs syndrome in systemic lupus erythematosus', Mayo Clinic Proceedings, vol. 75, no. 5, pp. 467-472.
Warrington, Kenneth J ; Moder, Kevin G. ; Mark Brutinel, W. / The shrinking lungs syndrome in systemic lupus erythematosus. In: Mayo Clinic Proceedings. 2000 ; Vol. 75, No. 5. pp. 467-472.
@article{3d25d5178f7e444ba7049fa91e0d5eb1,
title = "The shrinking lungs syndrome in systemic lupus erythematosus",
abstract = "A comprehensive review of the literature on shrinking lungs syndrome (SLS) in systemic lupus erythematosus involved a MEDLINE search (1965-1997) of case reports and clinical series of patients with the diagnosis of SLS. A total of 49 well-documented cases of SLS were reviewed. Shrinking lungs syndrome is characterized by unexplained dyspnea, a restrictive pattern on pulmonary function test results, and an elevated hemidiaphragm. The cause of SLS remains controversial, with several authors attributing the disorder to diaphragmatic weakness and others suggesting that chest wall restriction accounts for the clinical syndrome. No definitive therapy exists. Corticosteroids have been reported to lessen symptoms and improve pulmonary function in some patients with SLS, but other methods of treatment have occasionally been found to be helpful. Clinical presentation, method of diagnosis, pathogenesis, and treatment modalities are summarized in this review. An uncommon complication of systemic lupus erythematosus, SLS causes significant morbidity and, occasionally, mortality.",
author = "Warrington, {Kenneth J} and Moder, {Kevin G.} and {Mark Brutinel}, W.",
year = "2000",
language = "English (US)",
volume = "75",
pages = "467--472",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "5",

}

TY - JOUR

T1 - The shrinking lungs syndrome in systemic lupus erythematosus

AU - Warrington, Kenneth J

AU - Moder, Kevin G.

AU - Mark Brutinel, W.

PY - 2000

Y1 - 2000

N2 - A comprehensive review of the literature on shrinking lungs syndrome (SLS) in systemic lupus erythematosus involved a MEDLINE search (1965-1997) of case reports and clinical series of patients with the diagnosis of SLS. A total of 49 well-documented cases of SLS were reviewed. Shrinking lungs syndrome is characterized by unexplained dyspnea, a restrictive pattern on pulmonary function test results, and an elevated hemidiaphragm. The cause of SLS remains controversial, with several authors attributing the disorder to diaphragmatic weakness and others suggesting that chest wall restriction accounts for the clinical syndrome. No definitive therapy exists. Corticosteroids have been reported to lessen symptoms and improve pulmonary function in some patients with SLS, but other methods of treatment have occasionally been found to be helpful. Clinical presentation, method of diagnosis, pathogenesis, and treatment modalities are summarized in this review. An uncommon complication of systemic lupus erythematosus, SLS causes significant morbidity and, occasionally, mortality.

AB - A comprehensive review of the literature on shrinking lungs syndrome (SLS) in systemic lupus erythematosus involved a MEDLINE search (1965-1997) of case reports and clinical series of patients with the diagnosis of SLS. A total of 49 well-documented cases of SLS were reviewed. Shrinking lungs syndrome is characterized by unexplained dyspnea, a restrictive pattern on pulmonary function test results, and an elevated hemidiaphragm. The cause of SLS remains controversial, with several authors attributing the disorder to diaphragmatic weakness and others suggesting that chest wall restriction accounts for the clinical syndrome. No definitive therapy exists. Corticosteroids have been reported to lessen symptoms and improve pulmonary function in some patients with SLS, but other methods of treatment have occasionally been found to be helpful. Clinical presentation, method of diagnosis, pathogenesis, and treatment modalities are summarized in this review. An uncommon complication of systemic lupus erythematosus, SLS causes significant morbidity and, occasionally, mortality.

UR - http://www.scopus.com/inward/record.url?scp=0034065604&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034065604&partnerID=8YFLogxK

M3 - Article

C2 - 10807075

AN - SCOPUS:0034065604

VL - 75

SP - 467

EP - 472

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 5

ER -